Physician profile
Sergey Grachev
NPI 1487629614
$8,568.30
in general payments reported to CMS, 2019-2025
18 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,253 · 2020: $268 · 2021: $398 · 2022: $1,358 · 2023: $38.31 · 2024: $3,736 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,872 · Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,872.36 |
| Food and Beverage | $1,418.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $3,125.48 | 2024 | |
| Intuitive Surgical, INC. | $2,909.54 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $918.30 | 2022 | |
| Davol INC. | $421.52 | 2019-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $258.48 | 2024 | Phasix Mesh |
| Kerecis Limited | $249.56 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Tela Bio, INC. | $194.67 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $118.05 | 2019-2021 | |
| Organogenesis INC. | $116.22 | 2024-2025 | Nushield, Cygnus Matrix |
| Integra Lifesciences Corporation | $69.76 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Conmed Corporation | $55.56 | 2019 | |
| Ethicon US, LLC | $36.25 | 2020 | |
| Medtronic, INC. | $22.93 | 2025 | Transorb |
| Convatec INC. | $19.33 | 2024 | |
| Teleflex LLC | $15.92 | 2025 | Weck |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $13.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $11.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Grachev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.